Selective and dual action orally active inhibitors of thrombin and factor Xa.
Article Details
- CitationCopy to clipboard
Young RJ, Brown D, Burns-Kurtis CL, Chan C, Convery MA, Hubbard JA, Kelly HA, Pateman AJ, Patikis A, Senger S, Shah GP, Toomey JR, Watson NS, Zhou P
Selective and dual action orally active inhibitors of thrombin and factor Xa.
Bioorg Med Chem Lett. 2007 May 15;17(10):2927-30. Epub 2007 Mar 30.
- PubMed ID
- 17420122 [ View in PubMed]
- Abstract
The synthetic entry to new classes of dual fXa/thrombin and selective thrombin inhibitors with significant oral bioavailability is described. This was achieved through minor modifications to the sulfonamide group in our potent and selective fXa inhibitor (E)-2-(5-chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-(morpholin-4-yl)-2-oxoethyl ]-2-oxopyrrolidin-3-yl}ethenesulfonamide and these observed activity changes have been rationalised using structural studies.
DrugBank Data that Cites this Article
- Binding Properties